Top Story

ACC launches Statin Intolerance App

July 4, 2015

The American College of Cardiology has launched a free app designed to aid clinicians in the management and treatment of patients who report adverse muscular symptoms while on statin therapy, according to a press release.

Using the Statin Intolerance App, clinicians can respond to a series of questions that assess a patient’s tolerance to their current statin prescription. Then, clinicians can follow recommended cycles of discontinuation and rechallenge to identify the most appropriate statin and dose for a patient or to determine whether a patient is statin intolerant. The app also compares statin characteristics and drug interactions to assist clinicians in selecting a primary cholesterol-lowering therapy.

FDA News

FDA clears scoring balloon catheters with larger diameter

July 3, 2015
Spectranetics recently announced that it has received FDA 510(k) clearance for a scoring balloon catheter in diameters of 7 mm and 8 mm to treat a narrowed fistula…
In the Journals

Physician urges FDA not to lift restrictions on drug makers’ claims about their products

July 3, 2015
Drug regulations and a governing body to mandate them is a necessity for patients’ safety and health care providers’ peace-of-mind, according to a recently…
Lori C. Jordan, MD, PhD In the Journals

ED rapid response plan helps diagnose pediatric stroke symptoms

July 2, 2015
Among children presenting to the ED of a single center with brain attacks when a pediatric acute stroke protocol was activated, 40% had a stroke or other neurological…
In the Journals

CHD linked to osteoporosis in older adults

July 2, 2015
Older adults with a history of coronary heart disease have a substantially lower cortical volumetric bone mineral density at the distal radius, putting them at risk for…
More News Headlines »
CME
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
morganatic-roan
morganatic-roan